USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ELECTRONIC BIOSCIENCES, INC.
City: SAN DIEGO
State: CA
Zip+4: 92121-4207
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $741,839.00 4
SBIR Phase II $1,800,317.00 2

Award List:

Nanopore Based Methods for Enantiomer Differentiation

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Eric Ervin
Award Amount: $168,098.00
Abstract:
DESCRIPTION (provided by applicant): The overall aim of this Phase I program is to develop a new, robust nanopore platform for the differentiation of pharmacologically relevant enantiomers in clinical samples. Enantiomer screening is an important aspect of drug manufacturing and pharmacokinetic… More

Nanopatch System for Next Generation Ion Channel Recordings

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Geoffrey Barrall – 858-228-3205
Award Amount: $800,329.00
Abstract:
DESCRIPTION (provided by applicant): This Phase II SBIR program aims to further develop Electronic Bio Sciences' (EBS) Nanopatch system for ion channel measurements. The proposed system will allow high sensitivity measurements previously only attainable with the patch clamp method to be… More

Development of an in vitro assay as correlate of passive immune protection against botulinum neurotoxin to minimize use of whole animal testing

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency / Branch: DOD / CBD
Principal Investigator: Eric Ervin, Vice President R&D - EBS Utah – (801) 582-0146
Award Amount: $149,949.00
Abstract:
This Small Business Innovation Research Phase I project will develop a non-animal based in-vitro assay for determining the efficacy of Botulinum (BoNT) neutralizing therapeutics; the dual nanopore assay (DNPA). New technologies are currently needed in order to facilitate the development and approval… More

Development of an in vitro assay as correlate of passive immune protection against botulinum neurotoxin to minimize use of whole animal testing

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency / Branch: DOD / CBD
Principal Investigator: Eric Ervin, Vice President of R&D – (801) 582-0146
Award Amount: $999,988.00
Abstract:
This Small Business Innovation Research project will develop a non-animal based in vitro assay for determining the efficacy of Botulinum (BoNT) neutralizing therapeutics. New technologies are currently needed in order to facilitate the development and approval of BoNT vaccines and therapies and… More

Encapsulated Lipid Bilayer Based Assay for Assessing Botulinum Neurotoxin Potency

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Eric Ervin – 858-412-1705
Award Amount: $184,864.00
Abstract:
DESCRIPTION (provided by applicant): Unknown or poorly understood differences in the potency of therapeutics containing the botulinum neurotoxin Type A (BoNT/A) could result in over or under dosing of patients. The potency of BoNT/A therapeutics is currently assessed using a mouse intraperitoneal… More

Accurate, long read length, whole human genome sequencing under 100

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Anna Schibel
Award Amount: $238,928.00
Abstract:
DESCRIPTION (provided by applicant): The aim of this project is to investigate a simple method for slowing down the rate of electrophoretic translocation of DNA through a nanopore. Unique modulations of current across nanopores produced by individual basesduring such translocation forms the basis of… More